Women's GLP-1 journeys are shaped by hormonal factors that don't apply to men. Understanding how menstrual cycles, PCOS, perimenopause, and contraception interact with GLP-1 helps you set realistic expectations and get the most from treatment.
Weight naturally fluctuates 1–3 kg across the menstrual cycle due to hormonal fluid retention. This means weekly weigh-ins may show apparent 'gains' that are entirely hormonal, not fat. Track trends over 4+ weeks rather than week-to-week comparisons.
GLP-1 is showing particular promise for women with PCOS. Weight loss improves insulin sensitivity, which in turn often normalises hormonal imbalances — including testosterone levels and menstrual regularity. Some women with PCOS experience return of ovulation, which has fertility implications (see family planning article).
Perimenopause (typically 40s–50s) brings declining oestrogen, which shifts fat distribution toward the abdomen and slows metabolism. GLP-1 can counteract some of these changes, but weight loss may be slower than for younger women. This is normal — not a sign the medication isn't working.
GLP-1 slows gastric emptying, which may reduce the absorption consistency of oral contraceptives. Current guidance suggests using a barrier method as backup contraception for the first 4 weeks after starting or dose-increasing GLP-1. Discuss with your prescriber.
Getting 100g+ of protein daily on a reduced appetite is hard. Strategic timing makes it more achievable — and more effective for muscle preservation.
Medication helps with appetite. But the mental skills for sustainable weight management — resilience, flexibility, self-compassion — must be built intentionally.
People who share their journey with a community — online or in person — consistently achieve better outcomes. Here's why, and where to find yours.